| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 161.11B | 180.64B | 127.39B | 127.06B | 153.33B | 148.13B |
| Gross Profit | 57.62B | 66.28B | 46.64B | 46.24B | 60.65B | 58.49B |
| EBITDA | 33.77B | 39.74B | 26.56B | 24.68B | 39.11B | 39.20B |
| Net Income | 18.53B | 15.73B | 10.91B | 10.44B | 20.45B | 21.19B |
Balance Sheet | ||||||
| Total Assets | 267.89B | 278.36B | 244.29B | 250.94B | 254.17B | 243.31B |
| Cash, Cash Equivalents and Short-Term Investments | 47.95B | 54.92B | 59.78B | 64.65B | 64.12B | 67.06B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 37.67B | 45.90B | 25.61B | 22.66B | 29.06B | 34.53B |
| Stockholders Equity | 230.08B | 232.32B | 218.56B | 228.16B | 224.99B | 208.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.43B | 8.89B | 15.54B | 2.20B | 5.53B |
| Operating Cash Flow | 0.00 | 9.18B | 23.41B | 30.19B | 12.99B | 15.72B |
| Investing Cash Flow | 0.00 | -6.97B | -11.42B | -12.37B | -5.78B | -11.60B |
| Financing Cash Flow | 0.00 | -9.04B | -16.20B | -17.15B | -7.95B | -6.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥319.06B | 9.63 | 7.67% | 0.91% | 11.51% | 46.17% | |
74 Outperform | ¥581.36B | 20.53 | 5.25% | 2.13% | -7.11% | 68.57% | |
72 Outperform | ¥396.72B | 21.01 | ― | 2.50% | 1.45% | 0.37% | |
66 Neutral | ¥696.34B | 26.07 | 6.46% | 2.22% | 41.81% | 49.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥769.25B | 28.52 | 1.88% | 6.16% | 1.98% | -48.28% | |
55 Neutral | ¥569.88B | 203.90 | 5.94% | 0.56% | 7.03% | -53.53% |